Abstract
subjects during a steady-state of acute and strong NO ality (Advanced Digimatic Osmometer) and inulin and PAH inhibition. To achieve this, we applied continuous, [13, 14] . Additional blood samples for determination of high-dose infusion of the NOS blocker -NMMA.
vasoactive hormones were drawn at baseline, at 45 min from the start of the experimental period and at the end. Plasma renin activity (PRA) plasma aldosterone and atrial natriur-
Subjects and methods
etic peptide (ANP) were measured by radioimmunoassy as described previously [15] . Urine samples collected at baseline, Subjects at 1 h and at the end of the experimental period were put directly on ice and analysed for nitrite plus nitrate and for Studies were carried out in nine healthy males (age range guanosine 3∞, 5∞-cyclic monophosphate (cGMP). Urinary 20-27 years). Their health status was assessed by medical nitrate was assayed after conversion into nitrite with nitrate history, physical examination and routine laboratory investi-reductase. The conversion was performed by incubation of gation. All participants gave their written informed consent urine samples with anaerobically grown Escherichia coli after extensive explanation of the protocol. The study proto-bacteria and ammonium formate [16 ] . In this assay, 100% col was approved by the University Hospital Ethical nitrate-to-nitrite conversion is achieved. Total nitrite (represCommittee for Studies in Humans.
enting endogenous nitrite and reduced nitrate) was assayed In each subject, two clearance studies were carried out on colorimetrically by a modification of the Griess reaction separate days at least 3 days apart, one with -NMMA (formation of a purple dye with sulfanilamide and N-naphinfusion, and one with vehicle infusion to provide a time thylethylenediamine). The Griess reaction was modified in control study. The order of the studies was randomized. The that the pH was adjusted to 2.9 because, at this pH, the studies were performed after at least 5 days of a diet absorbance signal is twice as high as without pH adjustment. containing 200 mmol sodium. In order to test the blockade cGMP in urine was measured using a radioimmunoassay kit of NO synthesis, we measured urinary nitrate and nitrite with tritium-labelled cGMP (Amersham International plc, excretion during the clearance experiments. For this purpose, Buckinghamshire, UK ). subjects started with a nitrate-restricted diet 5 days before the -NMMA and the time control experiment, and fasted
Calculations and statistics
for 12 h prior to the clearance study. During the experiments, only nitrate-free water was consumed. On the day prior to Clearances were calculated according to standard formula. the clearance studies, 400 mg of lithium carbonate was Mean arterial pressure (MAP) was calculated as the sum of ingested at 10 p.m.
one-third of systolic pressure and two-thirds of diastolic pressure. The results were expressed as means±standard Procedure error. For statistical analysis, the results of all nine clearance periods on both days were subjected to analysis of variance Adherence to the diet was monitored by 24 h urine collections for repeated measures, followed by post-hoc multiple comon the day before each clearance experiment. The subjects parisons with the Student-Newman-Keuls test if variance received an oral water load of 25 ml/kg between 7.30 and ratios reached statistical significance. P<0.05 was considered 8.30 a.m. Additional water, matching urine output, was significant. supplied throughout the clearance study. The clearance studies were performed in the seated position. An antecubital vein was catheterized bilaterally for separate blood sampling
Results
and infusions. At 9 a.m., a priming dose of a solution containing 10% inulin, to measure GFR, and 2.5% paraaminohippuric acid (PAH ), to measure effective renal plasma Adherence to the diet was shown by the results of the flow ( ERPF ), was given, followed by continuous infusion of 24 h urinary sodium excretions, which were 160±17 this solution throughout the remainder of the study. After and 169±27 mmol on the days before the time control at least 1 h equilibration, and when urine osmolality had study and the -NMMA study, respectively. ( Table 1) . During baseline periods, there were no signiand infused as a priming dose of 3 mg/kg body weight, ficant differences in any of the parameters measured followed by maintenance infusion of 3 mg/kg/h during 3 h. between the two study days. Notably, the effects of -The average volume infused was 170 ml over 3 h. This scheme NMMA infusion on renal function and blood pressure was chosen to achieve a period of steady-state, as is desirable were established quickly and were stably maintained for renal studies by means of clearance techniques. Urine over the entire 3 h infusion period ( Figure 1 ). To collection and midpoint blood sampling continued at 30 min improve clarity, the data presented in Table 1 150-180 min of -NMMA or vehicle infusion. We There was a slight, but significant decrease in urinary Abbreviations: U-cGMP and U-NO X , urinary excretions of guanosine 3∞,5∞-cyclic monophosphate and nitrite plus nitrate. sodium excretion during the time control study. However, a significantly greater reduction in sodium excretion, by more than half, was found upon -NMMA and control study reached statistical signific-NMMA infusion ( Table 1) . Similar changes were ance only in the final collection period ( Table 3) . observed with respect to chloride excretion. Changes in potassium excretion were not significantly different during the two experiments. The substantial decrease Discussion in fractional sodium excretion indicates that tubular sodium reabsorption was increased. This was associated with significant decreases in fractional lithium The main findings in this study are that (i) acute, systemic NOS inhibition induces profound antinatriurexcretion and maximum urine flow. Notably, whereas minimal urine osmolality increased, minimal urine esis and antidiuresis, which persist at a stable level for several hours when NOS inhibition is maintained, and sodium concentration decreased significantly.
No significant changes in PRA, plasma aldosterone that (ii) these effects are associated with a decrease in the fractional excretions of sodium and lithium, a or ANP were found ( Table 2) . Urinary cGMP excretions were similar before vehicle and before -NMMA decrease in minimal urine sodium concentration and an increase in minimal urine osmolality. These changes infusion (323±36 pmol/min vs 327±24 pmol/min, respectively). Only in the -NMMA study was there a were observed in the presence of a substantial decrease in renal plasma flow, a relatively smaller decrease in highly significant fall in cGMP excretion during the infusion period compared with baseline ( Table 3) , and GFR, and a small, but consistent elevation in blood pressure. cGMP excretion tended to be lower in the -NMMA study compared with the time control study (P= This is the first study in humans using continuous high-dose infusion of -NMMA to assess the effects 0.075). NO x excretions were also similar at baseline (742±48 vs 687±105 nmol/min, control vs -of sustained and strong NOS inhibition on renal sodium handling. Discrepant findings have been NMMA). NO x excretion decreased during the time control study. Against this background, a somewhat reported on the effects on sodium and water excretion in two other studies in humans. In both studies, -larger reduction in NO x excretion was observed during -NMMA infusion, but the difference between -NMMA was given as a bolus injection of 3 mg/kg, which caused a 7-8 mmHg blood pressure increase, restored within 2 h after cessation of infusion [11] .
Abbreviations: PRA, plasma renin activity; Ang I, angiotensin I; ANP, atrial natriuretic peptide.
In animals, NOS inhibition in non-hypertensive
epithelial sites, such as macula densa and glomerulus sodium excretion occurs [1, 2] . NOS inhibition has been demonstrated to reset the renal pressure-natriur- [30, 31] . Further, an inducible NOS has been described in rat and human proximal tubule epithelium [32, 33] , esis and pressure-diuresis curves towards higher pressures [17, 18] . This may be mediated by diminished which, upon stimulation, causes a decrease in Na+/K+-ATPase activity, an effect that can be inhibited by transmission of arterial pressure changes to interstitial hydrostatic pressure [5] . Indeed, moderate NOS block-NG-nitro--arginine (NLA) [7] . The physiological importance of this inducible NOS for renal electrolyte ade appears to lower renal interstitial pressure, but this effect is reversed to increased interstitial pressure handling under basal circumstances remains to be investigated. if the dosage is increased to a level that raises blood pressure substantially [19] . In rats, the NOS inhibitionThe present study is the first to demonstrate that, during maximal water diuresis, NOS blockade in induced rise in perfusion pressure that overrides its antinatriuretic effect seems to be Á20 mmHg [2] . This humans also markedly decreases minimal sodium concentration, whereas minimal urine osmolality increases. is considerably more than the increase in MAP achieved with NOS inhibition in the present study or In view of the latter, the decrease in minimal sodium concentration cannot be explained by a decrease in other human studies [10] [11] [12] .
The large drop in fractional sodium excretion in water reabsorption. These findings indicate that NOS inhibition stimulates sodium reabsorption in the dilutresponse to -NMMA is consistent with previous findings in humans [10] and animals [5, 20, 21] , indicating ing segment, or, in other words, that endogenous NO participates in inhibition of sodium reabsorption in an important role for NO in renal tubular sodium reabsorption. The decrease in fractional lithium reab-that segment. Constitutive NOS has been detected not only in the macula densa, but also in distal tubular sorption is compatible with increased proximal tubular reabsorption of sodium, since in humans lithium is cells in the thick ascending limb of Henle, and the cortical and medullary collecting duct [30, 31] . reabsorbed mainly in the proximal tubules, roughly in parallel with sodium [22] . However, some reabsorption Administration of the NO donors nitroglycerine and spermine NONOate has been shown to inhibit basal of lithium in Henle's loop may occur [23] , particularly during a low loop flow rate [24] . In animal studies [8] as well as antidiuretic hormone-stimulated [9] sodium absorption and osmotic water permeability in too, NOS blockers in low doses, that induced at the most a mild pressor response, were found to enhance isolated perfused cortical collecting ducts.
No changes were found in PRA, aldosterone and proximal reabsorption as assessed by lithium clearance [20, 21, 25] . Those studies that demonstrated decreases ANP. Regarding the renin-aldosterone axis, divergent effects of NOS inhibition have been reported, in proximal reabsorption upon NOS inhibition, as measured by lithium and phosphate clearance [26 ] or depending upon experimental model, dose, duration of the treatment and prevailing renin activity [34] [35] [36] [37] . micropuncture techniques [27] , used a high dosage that caused large blood pressure rises accompanied by In humans, no changes in plasma angiotensin II, aldosterone or arginine vasopressin were found after a natriuresis. As an exception, administration of -NMMA in spontaneously hypertensive rats was also single dose of -NMMA, but an 18% decrease in ANP levels was observed as a late effect [10] . However, this shown to cause natriuresis and diuresis associated with an increase in phosphate excretion in the absence of a observation is opposite to those in animal experiments and in vitro studies, where NOS inhibition was reported blood pressure rise [28] .
Our data do not allow us to discern between direct to increase ANP release [38] , whereas NO donors or agonists had an inhibitory effect [39] . In any case, it and indirect (haemodynamically induced) effects on proximal sodium reabsorption. We found that -is unlikely that the presently observed changes in renal sodium handling are mediated through changes in NMMA decreased PAH clearance profoundly, but hardly affected inulin clearance, which is in accord these humoral factors.
Urinary excretion of cGMP and NO x were measured with previous studies by others using a similar infusion regimen [29] or -NMMA bolus injection [10] . Thus as indices of, respectively, NO activity [40] and NO metabolism [41] . However, despite the unequivocal -NMMA induced a substantial increase in total renal resistance and filtration fraction. These changes, also circulatory and renal actions of -NMMA, the changes in these variables were small. For cGMP, a small, but known from animal studies [1, 2] , will promote proximal reabsorption by decreasing peritubular capillary significant decrease was found throughout the infusion of -NMMA, parallel with its functional effects. A hydrostatic pressure and increasing peritubular capillary oncotic pressure. However, NO has also been similar limited fall was found after single injection of -NMMA in humans, by others [10] . Notably, cGMP suggested to influence proximal tubular cell sodium transport directly. The NO donors sodium nitroprus-formation also depends on other mediators of cellular function, such as ANP [42] . For NO x , a significant side and S-nitroso-N-acetylpenicillamine inhibit the activity of the apical Na+/H+ exchanger in cultured decrease in urinary excretion was found during the time control study. A spontaneous fall in NO activity proximal tubule cells by stimulation of guanylate cyclase and cGMP production [6 ] . Although constitu-seems unlikely, and we assume that this indicates a
